Pancreatic cancer constitutes only 3% of cancer diagnoses yet it is the 4th leading cause of cancer death in women and the 5th in men with a 5-year survival of just 5%. While the Whipple procedure is potentially curative, only a small minority of patients are candidates.
What can we do for the vast majority of patients with advanced disease who aren’t candidates for surgery or radiation? As it turns out, there is quite a lot.
|Pancreatic cancer cells isolated into microspheroids and maintained in a 3-D environment.||Pancreatic cancer cells exposed to Trimetrexate – no effect.||Pancreatic cancer cells undergoing programmed cell death following exposure to Mitomycin C plus Irinotecan.|